ApprovalTrail

Approval · Notice of Compliance 7884 · 2006

RHOTRAL: Notice of Compliance 7884

Issued April 18, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7884
Date
April 18, 2006
Company
Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Antihypertensive and anti-anginal agent

Products in this notice

BrandDINStatus today
RHOTRAL01910140Cancelled Post Market
RHOTRAL01910159Cancelled Post Market
RHOTRAL01910167Cancelled Post Market

Medicinal ingredients